Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion
-
- STATUS
- Recruiting
-
- End date
- Apr 14, 2024
-
- participants needed
- 30
-
- sponsor
- Central Hospital, Nancy, France
Summary
Clinical diagnosis of adnexal torsion is difficult because the symptomatology is dominated by abrupt onset pelvic pain, an aspecific sign which does not allow a diagnosis of certainty to be made.
To confirm the diagnosis, the reference examination is pelvic ultrasound with Doppler flow analysis. However, its intake is low, its sensitivity varies from 46 to 73% depending on the studies. Other imaging techniques have been considered, such as MRI, with a sensitivity far superior to ultrasound, but its difficult accessibility, in particular in the context of an emergency, makes it unusable in clinical practice.
The use of ultrasound with the injection of an ultrasound contrast agent, strict intravascular, seems to be an interesting technique to assess the perfusion parameters of the ovary and improve the diagnostic sensitivity of the adnexal torsion. Its interest has already been demonstrated in the diagnosis of testicular torsion in animals but to date, no study has evaluated its contribution in adnexal torsion.
Description
The primary objective is to evaluate the diagnostic performance of contrast enhanced ultrasound for the diagnosis of adnexal torsion in women with suspected adnexal torsion.
The secondary objectives are:
- To describe the perfusion parameters of the ovaries by contrast enhanced ultrasound
- To compare performance diagnosis of contrast ultrasound and bidimensional Doppler for the detection of adnexal torsion.
- To describe the perfusion parameters of the ovarian as a function of the degree of adnexal torsion.
- To compare perfusion parameters before and after ovarian detorsion
- To describe perfusion parameters of the ovarian by using MicroVascular Flow technique
Details
| Condition | Adnexal Torsion |
|---|---|
| Treatment | Contrast Enhanced Ultrasound |
| Clinical Study Identifier | NCT04522219 |
| Sponsor | Central Hospital, Nancy, France |
| Last Modified on | 10 May 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer